The invention provides an immunogenic composition comprising: (a) a conjugate that is a capsular saccharide from GBS serotype I1 conjugated to a carrier protein; (b) a conjugate that is a capsular saccharide from GBS serotype Ib conjugated to a carrier protein; and (c) a conjugate that is a capsular saccharide from GBS serotype III conjugated to a carrier protein. The invention also provides a method for immunizing a patient against infection by GBS comprising the step of administering to the patient a conjugate that is a capsular saccharide from GBS conjugated to a diphtheria toxoid or derivative thereof, wherein the patient has been pre-immunized with a diphtheria toxoid or derivative thereof.
申请公布号
EP2616099(A1)
申请公布日期
2013.07.24
申请号
EP20110768149
申请日期
2011.09.16
申请人
NOVARTIS AG
发明人
BERTI, FRANCESCO;CONTORNI, MARIO;COSTANTINO, PAOLO;FINCO, ORETTA;GRANDI, GUIDO;MAIONE, DOMENICO;TELFORD, JOHN